Blood Transfusion is Associated With Adverse Outcomes in Pediatric Solid Tumor Oncology Patients Following Tumor Resection. Issue 3 (22nd August 2022)
- Record Type:
- Journal Article
- Title:
- Blood Transfusion is Associated With Adverse Outcomes in Pediatric Solid Tumor Oncology Patients Following Tumor Resection. Issue 3 (22nd August 2022)
- Main Title:
- Blood Transfusion is Associated With Adverse Outcomes in Pediatric Solid Tumor Oncology Patients Following Tumor Resection
- Authors:
- Acker, Shannon N.
Nolan, Margo M.
Prendergast, Connor
Lyttle, Bailey
Fares, Souha
Bensard, Denis D.
Partrick, David A. - Abstract:
- Abstract : Background: Packed red blood cell (PRBC) transfusion is a lifesaving intervention that also has proinflammatory and immunosuppressive effects. Adults with a malignancy who receive PRBC transfusion have increased rates of infection, tumor recurrence, and decreased survival. The effect of PRBC transfusion among children with solid tumors is unknown. Methods: We performed a retrospective review of all children who underwent operative resection of a solid tumor malignancy. Data collected included demographic information, location of operation, nadir hemoglobin, and any PRBC transfusion within 30 days of tumor resection. Results: Three hundred sixty children underwent tumor resection at our institution between 2002 and 2013; 194 (54%) received a perioperative blood transfusion. After adjusting for stage at diagnosis, tumor location, preoperative chemotherapy and nadir hemoglobin, blood transfusion was associated with a higher rate of postoperative infectious complications, shorter disease-free interval, and a higher rate of tumor recurrence. Each additional transfused unit increased the risk of postoperative infection (odds ratio 3.83; 95% confidence interval 1.21, 14.22, P =0.031). Conclusions: Among children with solid tumor malignancies, PRBC transfusion within 30 days of operation is associated with higher rates of postoperative infection. If transfusion becomes necessary, single unit increments should be transfused. Level of Evidence: Level III.
- Is Part Of:
- Journal of pediatric hematology/oncology. Volume 45:Issue 3(2023)
- Journal:
- Journal of pediatric hematology/oncology
- Issue:
- Volume 45:Issue 3(2023)
- Issue Display:
- Volume 45, Issue 3 (2023)
- Year:
- 2023
- Volume:
- 45
- Issue:
- 3
- Issue Sort Value:
- 2023-0045-0003-0000
- Page Start:
- 137
- Page End:
- 142
- Publication Date:
- 2022-08-22
- Subjects:
- pediatric oncology -- blood transfusion -- perioperative transfusion -- postoperative complications
Pediatric hematology -- Periodicals
Tumors in children -- Periodicals
618.9215 - Journal URLs:
- http://journals.lww.com/jpho-online/pages/default.aspx ↗
http://gateway.tx.ovid.com/ovidweb.cgi?T=JS&MODE=ovid&NEWS=n&PAGE=toc&D=ovft&AN=00043426-000000000-00000 ↗
http://www.jpho-online.com/ ↗
http://journals.lww.com/jpho-online/pages/default.aspx ↗
http://journals.lww.com ↗ - DOI:
- 10.1097/MPH.0000000000002530 ↗
- Languages:
- English
- ISSNs:
- 1077-4114
- Deposit Type:
- Legaldeposit
- View Content:
- Available online (eLD content is only available in our Reading Rooms) ↗
- Physical Locations:
- British Library DSC - 5030.183000
British Library DSC - BLDSS-3PM
British Library STI - ELD Digital store - Ingest File:
- 26899.xml